Instil Bio, Inc.(TIL)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TIL Instil Bio, Inc.

盘前交易 12-23 04:06:18 EST

20.61

+0.53

+2.64%

最高21.90	最低19.12	成交量12.79万
今开19.97	昨收20.08	日振幅13.84%
总市值1.34亿	流通市值4,927万	总股本652.59万
成交额264.43万	换手率5.35%	流通股本239.06万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"TIL","market":"US","secType":"STK","nameCN":"Instil Bio, Inc.","latestPrice":20.61,"timestamp":1734728400000,"preClose":20.08,"halted":0,"volume":127877,"delay":0,"floatShares":2390583,"shares":6525887,"eps":-11.55565,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.53,"latestTime":"12-23 04:06:18 EST","open":19.97,"high":21.9,"low":19.12,"amount":2644323.214542,"amplitude":0.138446,"askPrice":32.97,"askSize":200,"bidPrice":8.25,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-11.55565,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734964200000},"adr":0,"listingDate":1616126400000,"adjPreClose":20.61,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":20.61,"preClose":20.61,"latestTime":"16:11 EST","volume":65078,"amount":1341257.58,"timestamp":1734729085551},"volumeRatio":1.5225083672542477,"impliedVol":5.6162,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/TIL","defaultTab":"news","newsList":[{"id":"2493472472","title":"Instil Bio, Inc.盘中异动 股价大涨5.08%报21.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493472472","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493472472?lang=zh_cn&edition=full","pubTime":"2024-12-21 03:25","pubTimestamp":1734722727,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日03时25分，Instil Bio, Inc.股票出现波动，股价急速上涨5.08%。Instil Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221032527ab87db8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221032527ab87db8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TIL","BK4505","BK4139"],"gpt_icon":0},{"id":"2492135560","title":"Instil Bio, Inc.盘中异动 股价大跌5.21%报20.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492135560","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492135560?lang=zh_cn&edition=full","pubTime":"2024-12-19 00:28","pubTimestamp":1734539288,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日00时28分，Instil Bio, Inc.股票出现波动，股价快速下挫5.21%。截至发稿，该股报20.56美元/股，成交量2.637万股，换手率0.40%，振幅5.86%。Instil Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121900280895ea56e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121900280895ea56e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","TIL"],"gpt_icon":0},{"id":"2490486704","title":"Instil Bio, Inc.盘中异动 临近午盘大幅下挫5.16%报23.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490486704","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490486704?lang=zh_cn&edition=full","pubTime":"2024-12-12 00:49","pubTimestamp":1733935750,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日00时49分，Instil Bio, Inc.股票出现波动，股价急速下跌5.16%。Instil Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.40%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121200491195e8fdd3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121200491195e8fdd3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","TIL","BK4139"],"gpt_icon":0},{"id":"2490048848","title":"Instil Bio, Inc.盘中异动 早盘快速下跌5.73%报25.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490048848","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490048848?lang=zh_cn&edition=full","pubTime":"2024-12-10 22:40","pubTimestamp":1733841636,"startTime":"0","endTime":"0","summary":"北京时间2024年12月10日22时40分，Instil Bio, Inc.股票出现异动，股价急速跳水5.73%。Instil Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210224036984b0c66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210224036984b0c66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","TIL"],"gpt_icon":0},{"id":"2490776060","title":"Instil Bio, Inc.盘中异动 大幅拉升5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490776060","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490776060?lang=zh_cn&edition=full","pubTime":"2024-12-09 22:35","pubTimestamp":1733754918,"startTime":"0","endTime":"0","summary":"北京时间2024年12月09日22时35分，Instil Bio, Inc.股票出现波动，股价大幅上涨5.02%。Instil Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.41%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209223518984ac4e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209223518984ac4e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TIL","BK4139","BK4505"],"gpt_icon":0},{"id":"2489646920","title":"Instil Bio, Inc.盘中异动 早盘股价大跌5.88%报26.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489646920","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489646920?lang=zh_cn&edition=full","pubTime":"2024-12-05 23:54","pubTimestamp":1733414067,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日23时54分，Instil Bio, Inc.股票出现波动，股价大幅下跌5.88%。Instil Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.49%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205235427971be534&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205235427971be534&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TIL","BK4505"],"gpt_icon":0},{"id":"2488901001","title":"Instil Bio, Inc.盘中异动 股价大涨5.66%报28.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488901001","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488901001?lang=zh_cn&edition=full","pubTime":"2024-12-04 23:07","pubTimestamp":1733324862,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日23时07分，Instil Bio, Inc.股票出现波动，股价快速上涨5.66%。截至发稿，该股报28.31美元/股，成交量2.4446万股，换手率0.37%，振幅6.08%。Instil Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204230742971ba2b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204230742971ba2b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TIL","BK4505"],"gpt_icon":0},{"id":"2488967058","title":"Instil Bio, Inc.盘中异动 早盘大幅上涨5.09%报28.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488967058","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488967058?lang=zh_cn&edition=full","pubTime":"2024-12-02 22:59","pubTimestamp":1733151591,"startTime":"0","endTime":"0","summary":"北京时间2024年12月02日22时59分，Instil Bio, Inc.股票出现波动，股价大幅上涨5.09%。Instil Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202225951a266a83d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202225951a266a83d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TIL","BK4505"],"gpt_icon":0},{"id":"2487561978","title":"Instil Bio, Inc.盘中异动 早盘股价大跌6.33%报27.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2487561978","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487561978?lang=zh_cn&edition=full","pubTime":"2024-11-30 00:23","pubTimestamp":1732897397,"startTime":"0","endTime":"0","summary":"北京时间2024年11月30日00时23分，Instil Bio, Inc.股票出现异动，股价急速下挫6.33%。截至发稿，该股报27.82美元/股，成交量4.0372万股，换手率0.62%，振幅8.38%。Instil Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.24%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241130002317971aab49&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241130002317971aab49&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TIL","BK4505"],"gpt_icon":0},{"id":"2486102820","title":"Instil Bio, Inc.盘中异动 早盘大幅拉升5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486102820","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486102820?lang=zh_cn&edition=full","pubTime":"2024-11-27 22:34","pubTimestamp":1732718085,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日22时34分，Instil Bio, Inc.股票出现异动，股价大幅拉升5.25%。Instil Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112722344598e44ebb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112722344598e44ebb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TIL","BK4505","BK4139"],"gpt_icon":0},{"id":"2486803849","title":"Instil Bio, Inc.盘中异动 早盘股价大涨6.08%报27.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486803849","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486803849?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:39","pubTimestamp":1732545547,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时39分，Instil Bio, Inc.股票出现异动，股价快速拉升6.08%。Instil Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.29%。其相关个股中，Scholar Rock Holding Corporation、Bridgebio Pharma, Inc.、60 Degrees Pharmaceuticals, Inc.涨幅较大，Cognition Therapeutics, Inc.、木薯科学、Citius Pharmaceuticals, Inc.较为活跃，换手率分别为90.96%、68.30%、42.51%，振幅较大的相关个股有Kodiak Sciences Inc、Werewolf Therapeutics, Inc.、Anixa Biosciences, Inc.，振幅分别为106.46%、105.79%、105.63%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112522390798e44693&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112522390798e44693&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TIL","BK4505"],"gpt_icon":0},{"id":"2485629800","title":"Instil Bio, Inc.2024财年第三财季实现净利润-23.02百万美元，同比增加65.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485629800","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485629800?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:00","pubTimestamp":1732291218,"startTime":"0","endTime":"0","summary":"11月23日，Instil Bio, Inc.公布财报，公告显示公司2024财年第三财季净利润为-23.02百万美元，同比增加65.86%；其中营业收入为0.00美元，每股基本收益为-3.54美元。从资产负债表来看，Instil Bio, Inc.总负债96.23百万美元，其中短期债务1.76百万美元，资产负债比为0.03，流动比率为0.13。机构评级：截至2024年11月23日，当前有3家机构对Instil Bio, Inc.目标价做出预测，其中目标均价为100.33美元，其中最低目标价为11.00美元，最高目标价为180.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000036abd7b7d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000036abd7b7d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TIL"],"gpt_icon":0},{"id":"2485676782","title":"Instil Bio, Inc.盘中异动 股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485676782","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485676782?lang=zh_cn&edition=full","pubTime":"2024-11-22 23:23","pubTimestamp":1732289038,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日23时23分，Instil Bio, Inc.股票出现波动，股价快速拉升5.01%。Instil Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.60%。其相关个股中，Replimune Group, Inc.、Invizyne Technologies Inc.、奥麦罗制药涨幅较大，Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Molecular Templates, Inc.较为活跃，换手率分别为1586.00%、111.31%、82.01%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为55.96%、45.86%、38.02%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122232358abd7a947&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122232358abd7a947&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","TIL","BK4139"],"gpt_icon":0},{"id":"2485126728","title":"Instil Bio, Inc.盘中异动 股价大跌5.99%报24.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485126728","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485126728?lang=zh_cn&edition=full","pubTime":"2024-11-21 02:42","pubTimestamp":1732128161,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日02时42分，Instil Bio, Inc.股票出现异动，股价急速下跌5.99%。Instil Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121024241a2492f74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121024241a2492f74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TIL","BK4505"],"gpt_icon":0},{"id":"2484924983","title":"Instil Bio, Inc.盘中异动 早盘股价大涨6.55%报26.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484924983","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484924983?lang=zh_cn&edition=full","pubTime":"2024-11-19 23:56","pubTimestamp":1732031795,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日23时56分，Instil Bio, Inc.股票出现波动，股价急速上涨6.55%。截至发稿，该股报26.50美元/股，成交量1.0777万股，换手率0.17%，振幅6.03%。Instil Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.73%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111923563598e438b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111923563598e438b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","TIL"],"gpt_icon":0},{"id":"2484719196","title":"Instil Bio, Inc.盘中异动 快速下挫5.13%报25.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484719196","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484719196?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:51","pubTimestamp":1731941469,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时51分，Instil Bio, Inc.股票出现波动，股价大幅下跌5.13%。Instil Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822511098e4344e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822511098e4344e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","TIL","BK4139"],"gpt_icon":0},{"id":"2483273804","title":"Instil Bio, Inc.盘中异动 早盘股价大涨5.93%报33.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483273804","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483273804?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:30","pubTimestamp":1731594648,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时30分，Instil Bio, Inc.股票出现波动，股价急速上涨5.93%。Instil Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422304898e429ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422304898e429ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","TIL"],"gpt_icon":0},{"id":"2482738771","title":"Instil Bio, Inc.盘中异动 股价大涨5.99%报32.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482738771","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482738771?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:44","pubTimestamp":1731336272,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时44分，Instil Bio, Inc.股票出现波动，股价大幅拉升5.99%。截至发稿，该股报32.69美元/股，成交量5162股，换手率0.08%，振幅4.92%。Instil Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111224433a22ceb61&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111224433a22ceb61&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TIL","BK4505","BK4139"],"gpt_icon":0},{"id":"2481839444","title":"Instil Bio Inc 预计每股亏损2.11美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481839444","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481839444?lang=zh_cn&edition=full","pubTime":"2024-11-08 23:51","pubTimestamp":1731081081,"startTime":"0","endTime":"0","summary":"Instil Bio Inc 预计每股亏损2.11美元 - 财报前瞻Instil Bio Inc TIL.OQ TIL.O预计将在11月11日公布截至2024年9月30日的业绩报告(估计)，季度收入将有所增长。根据LSEG的数据，4位分析师的平均预期显示，这家总部位于德克萨斯州达拉斯市的公司预计将实现95万美元的营收。LSEG 的分析师平均预计 Instil Bio Inc 每股亏损 2.11 美元。华尔街对 Instil Bio Inc 的 12 个月目标价中位数为 120.00 美元，高于其上次收盘价 28.44 美元。11月8日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL4T3MF1S6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TIL"],"gpt_icon":0},{"id":"2481077985","title":"Instil Bio, Inc.盘中异动 早盘股价大跌5.52%报25.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481077985","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481077985?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:49","pubTimestamp":1730904585,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时49分，Instil Bio, Inc.股票出现波动，股价大幅下挫5.52%。截至发稿，该股报25.00美元/股，成交量1.3831万股，换手率0.21%，振幅5.10%。Instil Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.97%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622494698e40e7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622494698e40e7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","TIL","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"https://instilbio.com/","stockEarnings":[{"period":"1week","weight":-0.0619},{"period":"1month","weight":-0.1177},{"period":"3month","weight":-0.6889},{"period":"6month","weight":0.9952},{"period":"1year","weight":2.0132},{"period":"ytd","weight":1.7047}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Instil Bio, Inc.总部位于德克萨斯州达拉斯，于2018年8月在特拉华州注册成立。该公司是一家临床阶段生物制药公司，致力于开发创新的自体肿瘤浸润淋巴细胞（TIL）治疗细胞疗法，以治疗癌症患者。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.173004},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.036947},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.080585},{"month":4,"riseRate":0.25,"avgChangeRate":-0.133235},{"month":5,"riseRate":0,"avgChangeRate":-0.094412},{"month":6,"riseRate":0.25,"avgChangeRate":-0.066045},{"month":7,"riseRate":0.5,"avgChangeRate":0.043591},{"month":8,"riseRate":0.5,"avgChangeRate":0.036497},{"month":9,"riseRate":0.25,"avgChangeRate":0.913411},{"month":10,"riseRate":0.25,"avgChangeRate":-0.209964},{"month":11,"riseRate":0.25,"avgChangeRate":-0.189425},{"month":12,"riseRate":0.25,"avgChangeRate":-0.214359}],"exchange":"NASDAQ","name":"Instil Bio, Inc.","nameEN":"Instil Bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Instil Bio, Inc.(TIL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Instil Bio, Inc.(TIL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Instil Bio, Inc.,TIL,Instil Bio, Inc.股票,Instil Bio, Inc.股票老虎,Instil Bio, Inc.股票老虎国际,Instil Bio, Inc.行情,Instil Bio, Inc.股票行情,Instil Bio, Inc.股价,Instil Bio, Inc.股市,Instil Bio, Inc.股票价格,Instil Bio, Inc.股票交易,Instil Bio, Inc.股票购买,Instil Bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Instil Bio, Inc.(TIL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Instil Bio, Inc.(TIL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}